Most bought healthcare stocks in Q2 2012

See which Healthcare stocks institutional investors increased the most in Q2 2012, measured as net growth in reported share positions from Q1 2012 into Q2 2012. Notable additions at the top of this list include PFIZER INC (PFE), ABBOTT LABORATORIES (ABT), MERCK & CO. INC. (MRK), BOSTON SCIENTIFIC CORP (BSX). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Net change in reported shares (all institutional filers) by symbol4 symbols with net change in reported shares from all institutional filers.0.0035.4K70.7K106.1K141.5KNet change in reported shares (all institutional filers)PFEABTMRKBSXSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
PFEPFIZER INC128,630$3.87M02002
ABTABBOTT LABORATORIES98,454$7.91M01002
MRKMERCK & CO. INC.7,670$4.92M02002
BSXBOSTON SCIENTIFIC CORP1,900-$32.60K01001

Frequently asked questions about Most bought healthcare stocks in Q2 2012

  • What are the most bought Healthcare stocks in Q2 2012?

    The most bought healthcare stocks in Q2 2012 are those with the largest increase in reported share counts across institutional investors compared to Q1 2012, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q2 2012?

    Among filers in this sector, net additions were largest in companies such as PFIZER INC (PFE), ABBOTT LABORATORIES (ABT), MERCK & CO. INC. (MRK), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2012).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.